1. Home
  2. PRTA vs TWI Comparison

PRTA vs TWI Comparison

Compare PRTA & TWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • TWI
  • Stock Information
  • Founded
  • PRTA 2012
  • TWI 1890
  • Country
  • PRTA Ireland
  • TWI United States
  • Employees
  • PRTA N/A
  • TWI N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • TWI Steel/Iron Ore
  • Sector
  • PRTA Health Care
  • TWI Industrials
  • Exchange
  • PRTA Nasdaq
  • TWI Nasdaq
  • Market Cap
  • PRTA 472.1M
  • TWI 500.1M
  • IPO Year
  • PRTA N/A
  • TWI 1993
  • Fundamental
  • Price
  • PRTA $10.45
  • TWI $7.77
  • Analyst Decision
  • PRTA Buy
  • TWI Strong Buy
  • Analyst Count
  • PRTA 9
  • TWI 2
  • Target Price
  • PRTA $17.71
  • TWI $11.50
  • AVG Volume (30 Days)
  • PRTA 567.7K
  • TWI 517.2K
  • Earning Date
  • PRTA 11-06-2025
  • TWI 11-06-2025
  • Dividend Yield
  • PRTA N/A
  • TWI N/A
  • EPS Growth
  • PRTA N/A
  • TWI N/A
  • EPS
  • PRTA N/A
  • TWI N/A
  • Revenue
  • PRTA $11,786,000.00
  • TWI $1,801,577,000.00
  • Revenue This Year
  • PRTA N/A
  • TWI $0.65
  • Revenue Next Year
  • PRTA $672.02
  • TWI $4.84
  • P/E Ratio
  • PRTA N/A
  • TWI N/A
  • Revenue Growth
  • PRTA N/A
  • TWI N/A
  • 52 Week Low
  • PRTA $4.32
  • TWI $5.93
  • 52 Week High
  • PRTA $18.65
  • TWI $10.94
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 56.63
  • TWI 48.89
  • Support Level
  • PRTA $10.02
  • TWI $7.40
  • Resistance Level
  • PRTA $11.17
  • TWI $8.53
  • Average True Range (ATR)
  • PRTA 0.56
  • TWI 0.39
  • MACD
  • PRTA -0.07
  • TWI 0.04
  • Stochastic Oscillator
  • PRTA 37.37
  • TWI 36.80

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

About TWI Titan International Inc. (DE)

Titan International Inc is a manufacturer of wheels, tires, wheel and tire assemblies, and undercarriage systems and components for off-highway vehicles. The company operates through three segments namely Agricultural, Earthmoving/Construction, and Consumer. Geographically, business of the group can be seen in the United States, Europe / CIS, Latin America and Other international. Titan derives majority of the revenue from Agricultural segment which manufacture various agricultural equipment, including tractors, combines, plows, planters and irrigation equipment, and are sold directly to original equipment manufacturers and to the aftermarket through independent distributors, equipment dealers and Titan's own distribution centers.

Share on Social Networks: